Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Adam J. Esbenshade"'
Autor:
Matthew T. Clark, Danielle A. Rankin, Lauren S. Peetluk, Alisa Gotte, Alison Herndon, William McEachern, Andrew Smith, Daniel E. Clark, Edward Hardison, Adam J. Esbenshade, Anna Patrick, Natasha B. Halasa, James A. Connelly, Sophie E. Katz
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 12, Pp 1050-1059 (2022)
Objective Features of multisystem inflammatory syndrome in children (MIS‐C) overlap with other syndromes, making the diagnosis difficult for clinicians. We aimed to compare clinical differences between patients with and without clinical MIS‐C dia
Externí odkaz:
https://doaj.org/article/92caa5f4552742fe95c071e3c7ca4b23
Autor:
Leonora Rose Slatnick, Kristen Miller, Halden F. Scott, Michele Loi, Adam J. Esbenshade, Anna Franklin, Alisa B. Lee-Sherick
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionDetermining which febrile pediatric hematology/oncology (PHO) patients will decompensate from severe infection is a significant challenge. Serum lactate is a well-established marker of illness severity in general adult and pediatric popul
Externí odkaz:
https://doaj.org/article/c2c31393487248edbbc6ed89dbe13a76
Autor:
Kasey Jackson, Victoria Anderson, Zhiguo Zhao, Carrie L. Kitko, James A. Connelly, Richard H. Ho, Ritu Banerjee, Daniel E. Dulek, Debra L. Friedman, Adam J. Esbenshade
Publikováno v:
Cancer. 129:1591-1601
Autor:
Leena Chehab, David R. Doody, Adam J. Esbenshade, Gregory M.T. Guilcher, Christopher C. Dvorak, Brian T. Fisher, Beth A. Mueller, Eric J. Chow, Jenna Rossoff
Publikováno v:
Journal of Clinical Oncology. 41:364-372
PURPOSE Infections pose a significant risk during therapy for childhood cancer. However, little is known about the risk of infection in long-term survivors of childhood cancer. METHODS We performed a retrospective observational study of children and
Autor:
Adam J. Esbenshade, Lu Lu, Debra L. Friedman, Kevin C. Oeffinger, Gregory T. Armstrong, Kevin R. Krull, Joseph P. Neglia, Wendy M. Leisenring, Rebecca Howell, Robyn Partin, Amy Sketch, Leslie L. Robison, Kirsten K. Ness
Publikováno v:
Journal of Clinical Oncology.
PURPOSE Cancer survivors develop cancer and treatment-related morbidities at younger than normal ages and are at risk for early mortality, suggestive of an aging phenotype. The Cumulative Illness Rating Scale for Geriatrics (CIRS-G) is specifically d
Autor:
Rachel L, Wattier, Adam J, Esbenshade
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 11:229-238
Reducing avoidable antimicrobial exposure to pediatric patients with cancer is achievable and necessary to promote optimal short- and long-term outcomes. Multiple evidence-based practices are already well established but should be more consistently i
Autor:
Melissa Z. Marx, Nicholas P. DeGroote, Christopher C. Dvorak, Richard Aplenc, Beth Fisher, Christopher Henchen, Brian T. Fisher, Adam J. Esbenshade, Jenny Weiland, Tamara P. Miller, Sally Jones
Publikováno v:
Journal of patient safety, vol 18, iss 3
J Patient Saf
J Patient Saf
OBJECTIVE Adverse event (AE) reporting is crucial for determining safety of trials. Adverse events are captured manually by clinical research associates (CRAs) and research nurses (RNs), and prior studies show underreporting. It is necessary to under
Autor:
William R. Otto, Christopher C. Dvorak, Craig L. K. Boge, Luis Ostrosky‐Zeichner, Adam J. Esbenshade, Michael L. Nieder, Sarah Alexander, William J. Steinbach, Ha Dang, Doojduen Villaluna, Lu Chen, Micah Skeens, Theoklis E. Zaoutis, Lillian Sung, Brian T. Fisher
Publikováno v:
Pediatric Transplantation. 27
Invasive fungal disease (IFD) is a major source of morbidity and mortality for hematopoietic cell transplant (HCT) recipients. Non-invasive biomarkers, such as the beta-D-glucan assay, may improve the diagnosis of IFD. The objective was to define the
Autor:
Hannah Walker, Adam J. Esbenshade, Stephanie Dale, Kanika Bhatia, Zhiguo Zhao, Franz E. Babl, Rachel Conyers, Gabrielle M. Haeusler
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(12)
Fever and infection are an important complication of childhood cancer therapy. Most research and guideline development has focussed on febrile neutropenia, with a paucity directed at non-neutropenic fever (NNF). We describe the clinical presentation,
Autor:
Pratik A. Patel, Nicholas P. DeGroote, Kasey Jackson, Thomas Cash, Sharon M. Castellino, Preeti Jaggi, Adam J. Esbenshade, Tamara P. Miller
Publikováno v:
CancerREFERENCES. 128(23)
Infections cause significant treatment-related morbidity during pediatric acute lymphoblastic leukemia/lymphoma (ALL/LLy) therapy. Fevers during periods without severe neutropenia are common, but etiologies are not well-described. This study sought t